Pharmacological and Clinical Efficacy of Picrorhiza kurroa and Its Secondary Metabolites: A Comprehensive Review

Journal: Molecules Publication Year: 2022 | Volume: 27 | Issue: 23 | Article Number: 8316 Authors: Almeleebia T.M., Alsayari A., Wahab S. Study Type: Review article PMID: 36500409 | PMCID: PMC9738980 | DOI: 10.3390/molecules27238316

Sep 21, 2026 | 1 min read

Research Gist

Kutki (Picrorhiza kurroa) is a Himalayan herb with a long history in Ayurveda, particularly for digestion and liver health. This comprehensive review brought together research on its traditional uses, chemistry, pharmacology, dosing and safety. The herb contains a range of active compounds, including iridoid glycosides, cucurbitacins, phenolics and terpenes. Its best-studied constituents are picroside-I and kutkoside, which together make up a large share of the plant's ethanolic extract and have shown strong liver-protective activity in preclinical studies. The review summarises research showing protection against several liver stressors, including alcohol, paracetamol and certain toxins, alongside antioxidant and anti-inflammatory activity. The authors note that no major adverse effects have been reported for the plant. In Somna Anu, Kutki's role is supportive — helping the body manage oxidative and inflammatory load rather than acting directly on sleep.

Key Learnings

  • Kutki contains iridoid glycosides, cucurbitacins, phenolics and terpenes.
  • Picroside-I and kutkoside are its best-studied liver-protective compounds.
  • Preclinical studies show protection against several liver stressors.
  • The review reports no major adverse effects for the plant.
  • This is a literature review — most of the evidence summarised is preclinical rather than from human trials.